Literature DB >> 14719786

Choosing a volume expander in critical care medicine.

Niranjan Kissoon1, Desmond Bohn.   

Abstract

The debate concerning the choice of crystalloids or colloids for resuscitation of the critically ill child is still unsettled. Moreover, the use of albumin in critically ill patients has been increasingly questioned because of the lack of clear-cut advantages over crystalloids as well as the concern for cost and the very minor risk of infection. Despite several meta-analyses addressing these issues, there is no data that supports the use of albumin unequivocally in any specific disease states. The suggestion that the use of albumin increases mortality in critically ill patients is not supported by data. There may be niche areas such as hypoalbuminic states, cirrhosis and burns where albumin may have distinct benefits. Alternatively synthetic colloids may be useful, however, concerns about coagulation problems and organ dysfunction persists.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14719786     DOI: 10.1007/bf02723823

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  34 in total

1.  Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes.

Authors:  A Phillips; A G Shaper; P H Whincup
Journal:  Lancet       Date:  1989-12-16       Impact factor: 79.321

2.  Nutritional assessment of intensive-care unit patients.

Authors:  M J Murray; H M Marsh; D N Wochos; K E Moxness; K P Offord; C W Callaway
Journal:  Mayo Clin Proc       Date:  1988-11       Impact factor: 7.616

3.  Randomised controlled trial: comparison of colloid or crystalloid for partial exchange transfusion for treatment of neonatal polycythaemia.

Authors:  W Wong; T F Fok; C H Lee; P C Ng; K W So; Y Ou; K L Cheung
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-09       Impact factor: 5.747

4.  Maintenance of serum albumin levels in pediatric burn patients: a prospective, randomized trial.

Authors:  D G Greenhalgh; T A Housinger; R J Kagan; M Rieman; L James; S Novak; L Farmer; G D Warden
Journal:  J Trauma       Date:  1995-07

5.  Serum protein levels in critically ill surgical patients.

Authors:  J A Bradley; K J Cunningham; V J Jackson; D N Hamilton; I M Ledingham
Journal:  Intensive Care Med       Date:  1981       Impact factor: 17.440

6.  Randomised controlled trial of colloid or crystalloid in hypotensive preterm infants.

Authors:  K W So; T F Fok; P C Ng; W W Wong; K L Cheung
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-01       Impact factor: 5.747

7.  Serum albumin and colloid osmotic pressure in survivors and nonsurvivors of prolonged critical illness.

Authors:  M C Blunt; J P Nicholson; G R Park
Journal:  Anaesthesia       Date:  1998-08       Impact factor: 6.955

8.  Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock.

Authors:  E C Rackow; J L Falk; I A Fein; J S Siegel; M I Packman; M T Haupt; B S Kaufman; D Putnam
Journal:  Crit Care Med       Date:  1983-11       Impact factor: 7.598

9.  Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion.

Authors:  G J Quinlan; M P Margarson; S Mumby; T W Evans; J M Gutteridge
Journal:  Clin Sci (Lond)       Date:  1998-10       Impact factor: 6.124

10.  Accumulation of hydroxyethyl starch (HES) in the liver of patients with renal failure and portal hypertension.

Authors:  H P Dienes; C D Gerharz; R Wagner; M Weber; H D John
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.